Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

GoodRx: Prescription Coupons

GoodRx: Prescription Coupons

By GoodRx

GoodRx is a medical app providing prescription discount coupons and telehealth services for uninsured patients on iOS and Android.

The App DNA

What makes this app unique?

Users hire GoodRx to bypass high out-of-pocket pharmacy costs and access virtual care without traditional insurance, serving as a financial lifeline.

For Individuals seeking affordable prescription medications and virtual healthcare services without reliance on traditional health insurance.

What does it look like?

Key features

Prescription Discount Couponsedge

Digital coupons for pharmacy medication purchases at over 70,000 locations

GoodRx Care Directedge

Subscription-based telehealth visits for weight loss, birth control, and short-term medication refills

Medication Tracker and Remindersstandard

In-app pill tracker and alert system for daily prescription management

Drug Price Comparisonstandard

Real-time price checking across multiple pharmacy chains for specific medications

How much does it cost?

freemiumFree digital coupons and medication trackingSubscription-based telehealth access via GoodRx Care Direct

Freemium model combines free-to-use pharmacy discount tools with paid subscription access for virtual medical consultations.

Velocity

Maintenance developmentopaqueperformanceShow more...

With only one release provided in the history, the app currently operates at a maintenance cadence. The latest release notes are entirely opaque, offering no insight into specific feature development or bug fixes. There is no evidence of live operations or new content, suggesting the app is in a stable, low-frequency update cycle.

See all version history

Who built it?

GoodRx

2 apps tracked · Medical

GoodRx: Prescription SavingsGoodRx: Prescription Savings
Explore the full publisher profile

User Sentiment

What do users think recently?

Fresh user feedback skews excited. Users appreciate significant out-of-pocket prescription cost reductions provide essential financial relief for uninsured users and simplified interface design allows for quick and efficient pharmacy price comparisons, but report automated payment processing failures for treatment plans cause significant user frustration.

How are ratings & reviews evolving?

May 18: 49 reviews (41 positive · 1 neutral · 7 negative)49May 25: 41 reviews (37 positive · 0 neutral · 4 negative)Jun 1: 41 reviews (37 positive · 0 neutral · 4 negative)Jun 8: 40 reviews (37 positive · 1 neutral · 2 negative)Jun 15: 34 reviews (30 positive · 0 neutral · 4 negative)Jun 22: 40 reviews (35 positive · 0 neutral · 5 negative)Jun 29: 29 reviews (25 positive · 1 neutral · 3 negative)Jul 6: 40 reviews (35 positive · 0 neutral · 5 negative)Jul 13: 40 reviews (35 positive · 0 neutral · 5 negative)Jul 20: 30 reviews (29 positive · 1 neutral · 0 negative)Jul 27: 46 reviews (39 positive · 0 neutral · 7 negative)Aug 3: 32 reviews (30 positive · 0 neutral · 2 negative)Aug 10: 32 reviews (28 positive · 0 neutral · 4 negative)May 18Aug 10
Positive Neutral Negative
4.5

Weekly average review rating

Google Play
4.81 · 334k

What users say, by theme

What Users Love
  • Significant out-of-pocket prescription cost reductions provide essential financial relief for uninsured users
  • Simplified interface design allows for quick and efficient pharmacy price comparisons
What Frustrates Users
  • Automated payment processing failures for treatment plans cause significant user frustration
+ 1 more theme

50 of 50 recent reviews analyzed · high confidence · Excited overall

Read the full review analysis

Unlock 1 more frustration theme, each backed by review evidence.

Access the full report for free

Competition

Competitive landscape for GoodRx: Prescription Coupons

How's the Medical market?

GoodRx holds the #4 Free position in the US Medical category, maintaining this rank through a broad pharmacy network that independent discount apps cannot replicate. The gap between its free coupon utility and the paid telehealth subscription tier remains the primary friction point for user conversion.

Read the market outlook

The rivals identified

SingleCare Rx Pharmacy Coupons

By SingleCare

SingleCare operates in the exact same prescription discount niche with a high-velocity release cadence, directly challenging GoodRx's core value proposition.

  • Focuses exclusively on pharmacy discount transparency without the broader telehealth ecosystem overhead found in GoodRx.
  • Maintains a high release frequency of 5 updates in six months to optimize coupon redemption flows.
  • Directly targets the uninsured and underinsured demographic with a simplified, single-purpose coupon interface.
GoodRx: Prescription Coupons vs SingleCare Rx Pharmacy Coupons

Unlock the head-to-head verdict: where this rival wins, and where it loses.

Access the full report for free

The Analyst's Read

Key takeaways for GoodRx: Prescription Coupons

Where is it heading?

The digital pharmacy market is consolidating around integrated fulfillment models, leaving coupon-only apps like GoodRx exposed to PBM-led competition. GoodRx must transition its user base from transactional coupon usage to recurring telehealth subscriptions to maintain its market position, so the PM should prioritize payment reliability to prevent churn.

  • Payment processing failures in the latest version cause recurring user frustration, which risks long-term subscription retention.
  • High-intent traffic for pharmacy discounts remains a strong engagement loop, securing the app's position against discount-only rivals.

The SWOT

Core Strengths
  • 70,000-pharmacy network functions as a B2B distribution moat
  • High-intent traffic drives consistent affiliate revenue
  • Integrated telehealth subscription creates a secondary recurring revenue stream
Critical Frictions 3 weaknesses inside
Growth Levers
  • Expansion of pet medication discounts
  • Untapped B2B partnerships with independent clinics
  • Deeper integration of wearable health data
Market Threats 3 threats identified

Next best moves

1 Pivot · 1 Maintain

Rebuild payment retry logic because payment failures are a top-3 complaint → reduce churn

+ 1 more prioritized move

The counter-intuitive read

The app's #4 rank is its greatest vulnerability…

Read the full take

Feature gaps

Direct-to-door prescription delivery (available in NimbleRx but absent here) +1

Since the last report: GoodRx transitioned to a freemium model by gating telehealth services behind a subscription, while simultaneously surfacing new technical and transparency-related user complaints.

Bottom line

GoodRx dominates the prescription discount space through its massive pharmacy network, but payment friction in its telehealth tier threatens long-term retention, so the PM must prioritize payment-flow reliability to secure recurring subscription revenue.

Unlock 3 critical frictions, 3 market threats, 1 more prioritized move and the analyst’s take.

Access the full report for free

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by GoodRx: Prescription Coupons, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

GoodRx transitioned to a freemium model by gating telehealth services behind a subscription, while simultaneously surfacing new technical and transparency-related user complaints.

shifted

Freemium Model Adoption

declined

Emergence of Payment and Transparency Complaints

improved

Feature Repositioning

added

New SWOT Risk Factors

Cite this report

Marlvel.ai. “GoodRx: Prescription Coupons Intelligence Report.” Updated May 20, 2026. https://marlvel.ai/apps/com-goodrx

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0